Decreased dehydroepiandrosterone (DHEA) and dehydroepiandrosterone sulfate (DHEAS) concentrations in plasma of Alzheimer's disease (AD) patients

Sarah Aldred, P Mecocci

Research output: Contribution to journalArticle

37 Citations (Scopus)

Abstract

DHEA is secreted by the adrenal cortex and is also a neurosteroid. Its sulfate (DHEAS) is the most abundant steroid in circulation. The levels of both are seen to decline in concentration with age. Evidence is available for altered levels of DHEA and DHEAS in AD but is limited to relatively few studies assessing small cohorts. This study assessed plasma DHEA and DHEAS levels in AD sufferers (n=72) and compared them to age-matched controls (n=72). Plasma DHEA concentrations were significantly lower in AD patients compared to control (4.24+/-0.4ng/ml for AD; 3.38+/-0.3ng/ml for control, p=0.027, Mann-Whitney 1-tailed) and DHEA levels were significantly correlated to DHEAS levels in both control and AD conditions (Spearman's rho correlation coefficient=0.635 in controls and 0.467 in AD, p
Original languageEnglish
JournalArchives of Gerontology and Geriatrics
DOIs
Publication statusPublished - 7 Aug 2009

Keywords

  • Neurosteroids
  • Hormones in aging
  • Cognition during aging
  • Dementia

Fingerprint

Dive into the research topics of 'Decreased dehydroepiandrosterone (DHEA) and dehydroepiandrosterone sulfate (DHEAS) concentrations in plasma of Alzheimer's disease (AD) patients'. Together they form a unique fingerprint.

Cite this